Zevra therapeutics appoints neil f. mcfarlane as president, chief executive officer and director

Christal mickle transitions back to chief development officer celebration, fla., oct. 10, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a rare disease therapeutics company, today announced that neil f.
ZVRA Ratings Summary
ZVRA Quant Ranking